# Study of SM-88 in Advanced Cancers

> **NCT02562612** · PHASE1,PHASE2 · WITHDRAWN · sponsor: **Tyme, Inc**

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** SM-88

## Key facts

- **NCT ID:** NCT02562612
- **Lead sponsor:** Tyme, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2022-10
- **Primary completion:** 2023-10
- **Final completion:** 2023-10
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Study was never initiated. Never established sites or enrolled subjects.
- **Last updated:** 2022-07-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02562612

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02562612, "Study of SM-88 in Advanced Cancers". Retrieved via AI Analytics 2026-07-11 from https://api.ai-analytics.org/clinical/NCT02562612. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*